Quick Answer
MIRA PHARMACEUTICALS, INC. reported Shares Outstanding of 41.94 million shares for fiscal year 2025.
MIRA PHARMACEUTICALS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 41.94M | +153.2% |
| 2024 | 16.56M | +12.0% |
| 2023 | 14.78M | +11.0% |
| 2022 | 13.31M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 39.51M | +142.9% | +127.3% |
| June 30, 2025 | 17.39M | +17.6% | +3.4% |
| March 31, 2025 | 16.81M | +13.8% | +1.5% |
| December 31, 2024 | 16.56M | +12.0% | +1.8% |
| September 30, 2024 | 16.27M | +10.0% | +10.0% |
| June 30, 2024 | 14.78M | +11.0% | +0.0% |
| March 31, 2024 | 14.78M | — | +0.0% |
| December 31, 2023 | 14.78M | +11.0% | +0.0% |
- MIRA PHARMACEUTICALS, INC. showed an increase of +153.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, MIRA PHARMACEUTICALS, INC.’s shares outstanding has grown by 215.0% (from 13.31 million shares to 41.94 million shares).
- The most recent figure is from MIRA PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: